|
Alexandria Real Estate Equities Inc |
|
United States |
+1 (626) 578-0777 |
N/A |
|
|
|
Alexandria Real Estate Equities Inc |
|
United States |
6265780777 |
N/A |
|
|
|
Alexandria Real Estate Equities Inc |
|
United States |
(626) 578-0777 |
N/A |
|
|
|
Auriga Partners |
|
France |
+33 (1) 5330-0707 |
Series B |
|
|
|
Cycad Group LLC |
|
United States |
+1 (805) 684-6515 |
Series B |
|
|
|
Johnson & Johnson Innovation LLC (JJDC Inc), (Johnson & Johnson Development Corp Inc) |
Accelerator of early-stage innovation worldwide that forms collaborations between entrepreneurs and Johnson & Johnson’s global healthcare businesses. |
United States |
+1 (732) 524-3218 |
Series B |
|
|
|
Lux Capital Management LLC |
Research-driven investment firm focused on founding, seed and early stage investments in the physical and life sciences |
United States |
+1 (646) 475-4385 |
Series B |
|
|
|
Polaris Venture Partners Inc |
Multistage venture capital investors with focus Technology, Healthcare and Consumer |
United States |
+1 (781) 290-0770 |
Series B |
|
|
|
Skyline Ventures |
Life Sciences venture capital firm |
United States |
+1 (203) 564-1596 |
Series B |
|
|
|
SR One Ltd |
The venture capital unit of GlaxoSmithKline |
United States |
+1 (610) 567-1000 |
Series B |
|
|